Stephen Saad (Born: Stephen Bradley Saad) is a South African businessman as well as the founder and chief executive of Aspen Pharmacare. He was born on June 23, 1964, in Durban, South Africa.
Stephen Saad Age
Saad is 58 years old as of 2022, he was born on 23 June 1964 in Durban, South Africa. He celebrates his birthday on 23 June every year.
Saad’s height is not known to the public. However, she stands at an average height and moderate weight. We will update this section when the information is available.
Saad’s family details are known to the public. She was born and raised in Durban, South Africa as Stephen Bradley Saad. We will update this section once these pieces of information are available.
Saad attended the Durban High School in Durban. He graduated from the University of Natal, where he received a Bachelor of Commerce. He played rugby in Ireland and studied to become a chartered accountant.
Saad studied at the Durban High School in Durban. He is a graduate of the University of Natal, where he earned a Bachelor of Commerce. He played rugby in Ireland and studied to become a chartered accountant.
Stephen is married to his wife Lynda. The couple has four daughters together. The family Stephen and Lynda reside in the luxurious Saad house, which is in Durban along with their four kids..
Stephen Saad Net Worth
Saad’s net worth is $1.09 billion dollars as of 2021. He has accumulated his wealth fron his successful career as a businessman.
Saad, co-founded South Africa’s largest pharmaceuticals maker, Aspen Pharmacare, a public company traded on the Johannesburg Stock Exchange along with Gus Attridge in 1997. Aspen Pharmacare markets generic medicines in 150 countries. He is the Chief Executive officer of Aspen Pharmacare and works on its Board of Directors.
Saad was appointed as Chief Executive of the Aspen Group in January 1999. As the Aspen Group Chief Executive, his responsibilities extend to include the strategic positioning and global transactions, geographic expansion and product diversification of Aspen in developed as well as emerging markets as a leading multinational pharmaceutical company.